Literature DB >> 15313995

Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond.

David Moher1, Douglas G Altman, Kenneth F Schulz, Diana R Elbourne.   

Abstract

Mesh：

Year:  2004        PMID： 15313995      PMCID： PMC509049          DOI： 10.1503/cmaj.1040031

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  16 in total

Review 1.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

Authors:  D Moher; D J Cook; S Eastwood; I Olkin; D Rennie; D F Stroup
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

Review 2.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

3.  Value of flow diagrams in reports of randomized controlled trials.

Authors:  M Egger; P Jüni; C Bartlett
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

4.  Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.

Authors:  D Moher; A Jones; L Lepage
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

5.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

6.  The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist.

Authors:  P J Devereaux; Braden J Manns; William A Ghali; Hude Quan; Gordon H Guyatt
Journal:  Control Clin Trials       Date:  2002-08

7.  Reporting of safety data from randomised trials.

Authors:  J P Ioannidis; D G Contopoulos-Ioannidis
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

8.  Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.

Authors:  J P Ioannidis; J Lau
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

9.  The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

Authors:  Jan Bonhoeffer; Katrin Kohl; Robert Chen; Philippe Duclos; Harald Heijbel; Ulrich Heininger; Tom Jefferson; Elisabeth Loupi
Journal:  Vaccine       Date:  2002-12-13       Impact factor: 3.641

Review 10.  Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391
View more
  20 in total

1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Bull World Health Organ       Date:  2007-11       Impact factor: 9.408

2.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  BMJ       Date:  2007-10-20

3.  Developing a reporting guideline for social and psychological intervention trials.

Authors:  Paul Montgomery; Evan Mayo-Wilson; Sally Hopewell; Geraldine Macdonald; David Moher; Sean Grant
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

4.  [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies].

Authors:  E von Elm; D G Altman; M Egger; S J Pocock; P C Gøtzsche; J P Vandenbroucke
Journal:  Internist (Berl)       Date:  2008-06       Impact factor: 0.743

5.  Reporting guidelines for health care simulation research: Extensions to the CONSORT and STROBE statements.

Authors:  Adam Cheng; David Kessler; Ralph Mackinnon; Todd P Chang; Vinay M Nadkarni; Elizabeth A Hunt; Jordan Duval-Arnould; Yiqun Lin; David A Cook; Martin Pusic; Joshua Hui; David Moher; Matthias Egger; Marc Auerbach
Journal:  BMJ Simul Technol Enhanc Learn       Date:  2016-07-24

Review 6.  Appetite stimulants for people with cystic fibrosis.

Authors:  Diane McTavish; Judith Thornton
Journal:  Cochrane Database Syst Rev       Date:  2022-09-23

7.  The quality of reporting of RCTs used within a postoperative pain management meta-analysis, using the CONSORT statement.

Authors:  Victoria Borg Debono; Shiyuan Zhang; Chenglin Ye; James Paul; Aman Arya; Lindsay Hurlburt; Yamini Murthy; Lehana Thabane
Journal:  BMC Anesthesiol       Date:  2012-07-04       Impact factor: 2.217

Review 8.  Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients.

Authors:  J Yang; Z Guo; Z Wu; Y Wang
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 9.  Reporting quality of social and psychological intervention trials: a systematic review of reporting guidelines and trial publications.

Authors:  Sean P Grant; Evan Mayo-Wilson; G J Melendez-Torres; Paul Montgomery
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

Review 10.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.